![](/img/cover-not-exists.png)
A novel virotherapy-based immunotherapy approach to ovarian cancer using an IL-12–expressing oncolytic herpes simplex virus
Thomas, E.D., Meza-Perez, S., Bevis, K.S., Gillespie, Y.G., Randall, T., Langford, C., Alvarez, R.D.Volume:
141
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.04.464
Date:
June, 2016
File:
PDF, 167 KB
english, 2016